https://www.selleckchem.com/products/nhwd-870.html
2% vs 40.3%; P = 0.001) and were significantly more likely to be inadequately anticoagulated with warfarin (38.9% vs 28.6%; P = 0.008) than patients without dementia. After matching based on age, eGFR, LVEF, and CHA2DS2-VASC patients with dementia were significantly more likely to experience inferior overall survival (HR = 1.8; P = 0.001) and shorter time to thrombosis (HR = 2.3; P = 0.019).Conclusion Our findings speak in support of increased thrombotic and mortality risks in patients with dementia, possibly due to inadequate anticoag
Like
Comment
Share
